The biopharma industry’s response to COVID-19 – creating multiple vaccines and developing therapeutics to make patients healthier, faster – generated enormous investment leading to continued growth across Massachusetts. As the demand for talent continues to exceed available supply, it’s critically important that we collectively work to identify new ways to expand and diversify the pipeline.
 

During our June Town Hall, panelists will examine data and industry trends to discuss how the life sciences can build and sustain a talented and diverse workforce.